3SDG | Transcription Repressor Inhibitor | date | Jun 09, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Ethionamide Boosters Part 2: Combining Bioisosteric Replacem Structure-Based Drug Design To Solve Pharmacokinetic Issues Series Of Potent 1,2,4-Oxadiazole Ethr Inhibitors. | ||||||||||||||
authors | M.Flipo, M.Desroses, N.Lecat-Guillet, B.Villemagne, N.Blondiaux, C.Piveteau, V.Mathys, M.P.Flament, J.Siepmann, V.Villeret, A.Woh R.Wintjens, S.H.Soror, T.Christophe, H.K.Jeon, C.Locht, P.Brodin Prez, A.R.Baulard, N.Willand | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Hth-Type Transcriptional Regulator Ethr Chain: A Engineered: Yes |
Organism_scientific: Mycobacterium Tuberculosis Organism_taxid: 83332 Strain: H37rv Gene: Etar, Ethr, Mt3970, Rv3855 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 41 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.87 Å | ||||||||||||
ligand | 3SE BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors., Flipo M, Desroses M, Lecat-Guillet N, Villemagne B, Blondiaux N, Leroux F, Piveteau C, Mathys V, Flament MP, Siepmann J, Villeret V, Wohlkonig A, Wintjens R, Soror SH, Christophe T, Jeon HK, Locht C, Brodin P, Deprez BP, Baulard A, Willand N, J Med Chem. 2011 Nov 20. PMID:22098589 |
Data retrieval |
View 3SDG in 3D |
Visual 3D analysis of 3SDG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3SDG |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |